Hope for cancer patients: can thyroid medication be stopped after immunotherapy?
NCT ID NCT07421869
First seen Feb 26, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study looks at whether hypothyroidism caused by immune checkpoint inhibitors (a type of cancer immunotherapy) can get better after stopping the immunotherapy. Researchers want to see how many patients can safely stop taking thyroid hormone replacement (levothyroxine) and what factors predict recovery. The study involves 107 adult cancer patients who developed hypothyroidism during immunotherapy and have already stopped that treatment. Participants will gradually reduce their thyroid medication under close monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTHYROIDISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Internal Medicine, Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.